围胰腺周围微创治疗在治疗急性重症胰腺炎中的应用

摘要

Objective To discuss the clinical effect of minimally invasive treatment in SAP during the early and middle stage. Methods To divide 125 cases of SAP patients randomly into observing group (63 cases) and control group (62 cases). The observing group adopted routine placement laparoscope and control group adopted the laparotomy. Results In observing group, the timing of the operation, peri-operative bleeding, abdominal pain relief and recovery time, temperature recovery time anus exhaust time, irrigation drainage time, blood amylase recovery time and hospital time are all superior to control group. To compare every item, the P<0.05, the difference has statistics significance. In observing group, pancreatic tissue necrosis, pancreas abscess, pancreatic fistula intestinal fistula, pseudocyst pancreas and death are obviously lower than the control group. To compare every item, the P<0.05, the difference has statistics significance. Conclusion LPLD early stage treatment and SAP minimally invasive treatment have such characteristics, safe, convenient, effective in treatment and rare complications and so on, which should be widely used.%　　目的 探讨微创治疗在急性重症胰腺炎(SAP)中早期的应用临床效果.方法 将125例SAP患者随机分成观察组(63例)与对照组(62例),观察组采用常规置入腹腔镜,对照组采用开腹手术.结果 观察组患者的手术时间、术中出血量、腹痛缓解时间、体温恢复时间、肛门排气时间、灌洗引流时间、血淀粉酶恢复时间及住院时间均优于对照组患者,各项进行比较,P<0.05,差别均统计学意义.观察组患者胰腺及周围组织坏死、胰腺脓肿、胰瘘肠瘘、胰腺假性囊肿、死亡明显低于对照组患者,各项进行比较,P<0.05,差异具有统计学意义.结论 LPLD早期治疗SAP微创、安全、简便、临床疗效显著、并发症少等特点,值得临床推广.